csirt@kutim:~/threat-intel/cve/CVE-2026-0506

Katalog CVE

CVSS 8.1 · High EPSS 0,27%

Kerentanan Missing Authorization pada sap netweaver application server abap. Skor CVSS 3.1 8.1 (High) menurut sap.com.

Deskripsi (NVD)

Due to a Missing Authorization Check vulnerability in Application Server ABAP and ABAP Platform, an authenticated attacker could misuse an RFC function to execute form routines (FORMs) in the ABAP system. Successful exploitation could allow the attacker to write or modify data accessible via FORMs and invoke system functionality exposed via FORMs, resulting in a high impact on integrity and availability, while confidentiality remains unaffected.

Rincian

Terbit di NVD
13 Januari 2026
Terakhir diubah
17 Juni 2026
Status NVD
Analyzed
CVSS 3.1
8.1 (High), sumber sap.com
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-862: Missing Authorization
EPSS (30 hari)
0,27% peluang dieksploitasi; lebih tinggi dari 17,0% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
sap netweaver application server abap Versi 700
sap netweaver application server abap Versi 701
sap netweaver application server abap Versi 702
sap netweaver application server abap Versi 731
sap netweaver application server abap Versi 740
sap netweaver application server abap Versi 750
sap netweaver application server abap Versi 751
sap netweaver application server abap Versi 752
sap netweaver application server abap Versi 753
sap netweaver application server abap Versi 754
sap netweaver application server abap Versi 755
sap netweaver application server abap Versi 756
sap netweaver application server abap Versi 757
sap netweaver application server abap Versi 758
sap netweaver application server abap Versi 816

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.